The report mentioned that India's pharmaceutical industry is entering a decisive new phase marked by tighter supply chains, sustainable manufacturing pressures and an accelerated global shift toward advanced biologics.
The visit has brought together senior government, university and industry figures from both countries to showcase cutting-edge partnerships and innovations that are driving technological and societal progress.